Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enrichment of serum IgG4 in MuSK myasthenia gravis patients.
Vergoossen DLE, Ruiter AM, Keene KR, Niks EH, Tannemaat MR, Strijbos E, Lipka AF, van der Zijde ECJ, van Tol MJD, Bakker JA, Wevers BA, Westerberg E, Borges LS, Tong OC, Richman DP, Illa I, Punga AR, Evoli A, van der Maarel SM, Verschuuren JJ, Huijbers MG. Vergoossen DLE, et al. Among authors: ruiter am. J Neuroimmunol. 2022 Dec 15;373:577978. doi: 10.1016/j.jneuroim.2022.577978. Epub 2022 Oct 7. J Neuroimmunol. 2022. PMID: 36240543 Free article.
The face of myasthenia gravis.
Ruiter AM, Naber WC, Verschuuren JJGM, Tannemaat MR. Ruiter AM, et al. Neurology. 2020 Jul 14;95(2):89-90. doi: 10.1212/WNL.0000000000009782. Epub 2020 Jun 10. Neurology. 2020. PMID: 32522801 No abstract available.
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
Efgartigimod in refractory autoimmune myasthenia gravis.
Remijn-Nelissen L, Tannemaat MR, Ruiter AM, Campman YJM, Verschuuren JJGM. Remijn-Nelissen L, et al. Among authors: ruiter am. Muscle Nerve. 2024 Sep;70(3):325-332. doi: 10.1002/mus.28184. Epub 2024 Jun 20. Muscle Nerve. 2024. PMID: 38899431
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases.
van Dam KPJ, Wieske L, Stalman EW, Kummer LYL, van der Kooi AJ, Raaphorst J, van de Beek D, Verschuuren JJGM, Ruiter AM, Brusse E, van Doorn PA, Baars AE, van der Pol WL, Goedee HS, Ten Brinke A, van Ham SM, Rispens T, Kuijpers TW, Eftimov F; T2B! Immunity Against SARS‐CoV‐2 Study Group. van Dam KPJ, et al. Among authors: ruiter am. Eur J Neurol. 2024 Dec;31(12):e16409. doi: 10.1111/ene.16409. Epub 2024 Sep 5. Eur J Neurol. 2024. PMID: 39236312 Free PMC article.
27 results